Documentation of decisions and rationale

Introduction

Documentation of decisions and rationale refers to the systematic recording of important decisions, the reasons behind them, the evidence considered and the legal or professional standards applied. In biotechnology, this process is particularly important because decisions may affect patient safety, scientific research, environmental protection, product quality and public health.

Biotechnology organisations make decisions relating to clinical trials, genetic research, laboratory safety, manufacturing processes, product approvals and regulatory compliance. Proper documentation creates transparency and accountability by showing how and why a particular decision was made. It also helps regulators, courts, auditors and affected individuals examine whether the decision was lawful, reasonable and based on reliable information.

Legal framework in India

Several Indian laws and regulatory frameworks support the documentation of decisions and their underlying reasons.

1. Constitution of India: Article 14 guarantees equality before the law and protects against arbitrary State action. Article 21 protects life and personal liberty. Public authorities making decisions affecting individuals must act fairly and follow applicable legal procedures.

2. Drugs and Cosmetics Act, 1940: This legislation regulates the import, manufacture, distribution and sale of drugs and cosmetics. Decisions concerning drug approvals, manufacturing standards and regulatory enforcement must comply with statutory requirements.

3. New Drugs and Clinical Trials Rules, 2019: These rules establish requirements relating to clinical trial permissions, ethics committees, informed consent, safety reporting and compensation. Maintaining appropriate records helps demonstrate compliance with these requirements.

4. Digital Personal Data Protection Act, 2023: Where applicable provisions are in force, the Act regulates the processing of digital personal data. Biotechnology organisations handling genetic, clinical or patient information must consider applicable data protection obligations while maintaining decision records.

5. Companies Act, 2013: Section 118 requires companies to maintain minutes of proceedings of general meetings and meetings of the Board and its committees. This supports accountability in corporate decision-making, including decisions involving biotechnology operations.

Importance of documenting decisions and rationale

Documentation establishes a reliable record of institutional conduct. When a biotechnology company decides to discontinue a clinical trial, reject a research proposal or modify a manufacturing process, the record should explain the reasons for that decision.

Important elements generally include:

Decision details: The date, responsible authority and subject of the decision.

Supporting evidence: Scientific reports, laboratory results, expert opinions and risk assessments.

Legal basis: Relevant legislation, regulations, licences and regulatory requirements.

Reasoning: The factors considered and the justification for selecting a particular course of action.

Approval and review: Names or designations of approving officials and details of subsequent review.

Follow-up measures: Corrective actions, monitoring requirements and implementation deadlines.

These records help prevent arbitrary decisions and make it easier to identify errors, conflicts of interest or regulatory violations.

Application in biotechnology

In clinical research, ethics committees should document their reasons for approving, rejecting or requiring modifications to research proposals. Their records should reflect consideration of participant safety, informed consent, scientific validity and potential risks.

In biotechnology manufacturing, quality assurance teams should record decisions concerning rejected batches, deviations from standard operating procedures and corrective actions. A documented explanation helps establish whether the organisation followed appropriate quality-control procedures.

Similarly, decisions involving genetically modified organisms should record scientific risk assessments, regulatory permissions and environmental considerations. Such documentation can assist regulators in evaluating whether the organisation complied with applicable biosafety requirements.

Important case laws

1. S.N. Mukherjee v. Union of India (1990)

The Supreme Court recognised that recording reasons is an important component of fairness in administrative decision-making. Giving reasons helps demonstrate that the authority applied its mind and allows an affected person to understand the basis of the decision. This principle is relevant to regulatory decisions involving biotechnology approvals and disciplinary proceedings.

2. Kranti Associates Pvt. Ltd. v. Masood Ahmed Khan (2010)

The Supreme Court explained that recording reasons promotes transparency, accountability and fairness. It observed that reasoned decisions reduce arbitrariness and strengthen public confidence in judicial and administrative institutions. This principle supports maintaining clear explanations for decisions made by biotechnology regulators and ethics committees.

3. Siemens Engineering & Manufacturing Co. of India Ltd. v. Union of India (1976)

The Supreme Court emphasised that quasi-judicial authorities must provide reasons for their decisions. A reasoned order allows affected parties to understand the decision and enables effective judicial review. This principle is relevant where regulatory authorities make decisions concerning biotechnology licences or compliance disputes.

4. Mohinder Singh Gill v. Chief Election Commissioner (1978)

The Supreme Court established that the validity of an administrative order must generally be judged by the reasons stated in the order itself. Authorities cannot ordinarily improve an otherwise defective decision by introducing new reasons later through affidavits. This principle highlights the importance of documenting the actual rationale at the time a decision is made.

Challenges and compliance measures

Biotechnology organisations may face difficulties in maintaining complete records because scientific decisions often involve multiple departments, changing evidence and confidential information. Poor documentation can create difficulties during inspections, litigation and regulatory investigations.

Organisations should adopt standard decision-recording procedures, maintain secure electronic audit trails, establish approval hierarchies and periodically review documentation practices. Records should be accurate, accessible to authorised persons and protected against unauthorised alteration.

Conclusion

Documentation of decisions and rationale is an essential element of transparency, accountability and legal compliance in biotechnology. It demonstrates that decisions were based on relevant evidence, scientific assessment and applicable legal requirements. Indian judicial decisions consistently recognise the importance of reasoned administrative action. By maintaining accurate and systematic records, biotechnology organisations can reduce legal risks, improve regulatory compliance and strengthen public trust in scientific institutions.